Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia

M.H. de Aguiar Oliveira,; A.C. Moreira,; A. Rossi,; C. Cruz,

doi:10.1515/JPEM.1991.4.4.255

Cite this article

de Aguiar Oliveira,, M.H., Moreira,, A.C., Rossi,, A. and Cruz,, C.. "Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia" Journal of Pediatric Endocrinology and Metabolism, vol. 4, no. 4, 1991, pp. 255-262. https://doi.org/10.1515/JPEM.1991.4.4.255

de Aguiar Oliveira,, M., Moreira,, A., Rossi,, A. & Cruz,, C. (1991). Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia. Journal of Pediatric Endocrinology and Metabolism, 4(4), 255-262. https://doi.org/10.1515/JPEM.1991.4.4.255

de Aguiar Oliveira,, M., Moreira,, A., Rossi,, A. and Cruz,, C. (1991) Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia. Journal of Pediatric Endocrinology and Metabolism, Vol. 4 (Issue 4), pp. 255-262. https://doi.org/10.1515/JPEM.1991.4.4.255

de Aguiar Oliveira,, M.H., Moreira,, A.C., Rossi,, A. and Cruz,, C.. "Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia" Journal of Pediatric Endocrinology and Metabolism 4, no. 4 (1991): 255-262. https://doi.org/10.1515/JPEM.1991.4.4.255

de Aguiar Oliveira, M, Moreira, A, Rossi, A, Cruz, C. Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia. Journal of Pediatric Endocrinology and Metabolism. 1991;4(4): 255-262. https://doi.org/10.1515/JPEM.1991.4.4.255

Copy to clipboard

Download: BibTeX EndNote RIS

Salivary 17-α-Hydroxyprogesterone in Management of Congenital Adrenal Hyperplasia

Journal and Issue

Articles in the same Issue